科文斯现更名为Labcorp Drug Development

作为一家全球性公司,我们致力于为千百万人的福祉共同创新,持续为您带来更先进的医学突破。

了解详情

Covance Gene Therapies

基因疗法

Gene therapies have already had a profound impact on patients' lives and have the potential to impact many more, in particular those with rare genetic diseases. Whether you're developing a viral vector-based therapy, such as an adeno-associated virus (AAV) or lentivirus (lenti) product, or applying gene editing technologies such as CRISPR/cas9, you'll benefit from our Expert Teams' deep knowledge and experience.

Assess safety, establish proof of concept and feasibility to support IND/IMPD/CTA submissions, and rapidly transition to first-in-human trials

Conduct Phase I, II, and III trials to support BLA/MAA submissions and preparation for post-marketing studies

Conduct real-world evidence studies, fulfill post-marketing commitments & ensure patient access to your gene therapy

让我们开始探讨合作吧

欲了解详情? 

联系我们